title: Gadolinium-enhanced pulmonary magnetic resonance angiography in the diagnosis of acute pulmonary embolism: a prospective study on 48 patients.
abstract: OBJECTIVE
  Gadolinium-enhanced pulmonary magnetic resonance angiography (MRA) can be an option in patients with a history of previous adverse reaction to iodinated contrast material and renal insufficiency. Radiation is also avoided. The aim of this study is to prospectively compare the diagnostic value of MRA with that of a diagnostic strategy, taking into account catheter angiography, computed tomography angiography (CTA), and lung scintigraphy [ventilation-perfusion (VQ)].
  
  
  METHODS
  Magnetic resonance angiography was done in 48 patients with clinically suspected pulmonary embolism (PE) using fast gradient echo coronal acquisition with gadolinium. Interpretation was done with native coronal images and multiplanar maximum intensity projection reconstructions. Results were compared to catheter angiography (n=15), CTA (n=34), VQ (n=45), as well as 6-12 months clinical follow-ups, according to a sequenced reference tree.
  
  
  RESULTS
  The final diagnosis of PE was retained in 11 patients (23%). There were two false negatives and no false positive results with MRA. Computed tomography angiography resulted in no false negatives or false positives. Magnetic resonance angiography had a sensitivity of 82% and a specificity of 100%.
  
  
  CONCLUSIONS
  In our study, pulmonary MRA had a sensitivity of 82% and a specificity of 100% for the diagnosis of PE, with slightly less sensitivity than CTA. In the diagnostic algorithm of PE, pulmonary MRA should be considered as an alternative to CTA when iodine contrast injection or radiation is a significant matter.
authors.affiliation: Centre hospitalier de l'Université de Montréal (CHUM), Hôpital Saint-Luc, Radiology Department, St-Denis Street, Montreal, Quebec, Canada H2X 3J4.
authors.forename: Bartlomiej
authors.initials: B
authors.lastname: Pleszewski
authors.forename: Carl
authors.initials: C
authors.lastname: Chartrand-Lefebvre
authors.forename: Salah D
authors.initials: SD
authors.lastname: Qanadli
authors.forename: Renée
authors.initials: R
authors.lastname: Déry
authors.forename: Pierre
authors.initials: P
authors.lastname: Perreault
authors.forename: Vincent L
authors.initials: VL
authors.lastname: Oliva
authors.forename: Julie
authors.initials: J
authors.lastname: Prenovault
authors.forename: Assia
authors.initials: A
authors.lastname: Belblidia
authors.forename: Gilles
authors.initials: G
authors.lastname: Soulez
mesh_terms: D000208:Acute Disease; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003287:Contrast Media / Q000008:administration & dosage*; D005260:Female; D005500:Follow-Up Studies; D019786:Gadolinium DTPA; D006801:Humans; D007090:Image Interpretation, Computer-Assisted / Q000379:methods; D018810:Magnetic Resonance Angiography / Q000379:methods*; D008297:Male; D008875:Middle Aged; D015588:Observer Variation; D011446:Prospective Studies; D011651:Pulmonary Artery / Q000000981:diagnostic imaging / Q000473:pathology; D011655:Pulmonary Embolism / Q000175:diagnosis*; D011877:Radionuclide Imaging; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D014057:Tomography, X-Ray Computed / Q000379:methods
chemical_list: D003287:Contrast Media; D019786:Gadolinium DTPA